Published in Br J Radiol on December 01, 2008
Pulmonary involvement in ANCA-associated vasculitis from the view of the pulmonologist. Clin Exp Nephrol (2012) 0.95
Eight Years Follow-up of a Case with Idiopathic Pulmonary Hemosiderosis After Corticosteroid Therapy. N Am J Med Sci (2012) 0.75
Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol (2001) 7.40
Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med (1999) 2.92
Diagnosis and treatment of enterovesical fistulae. Colorectal Dis (2005) 2.48
A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun (2002) 2.21
Predictive value of clinical features for the obstructive sleep apnoea syndrome. Eur Respir J (1996) 1.91
Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease. N Engl J Med (1984) 1.88
Pathophysiology of obstructive sleep apnoea. Eur Respir J (1995) 1.85
Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Respir J (2000) 1.80
Role for macrophage migration inhibitory factor in asthma. Proc Natl Acad Sci U S A (2005) 1.79
Reversible hypercapnia in chronic obstructive pulmonary disease: a distinct pattern of respiratory failure with a favorable prognosis. Am J Med (1997) 1.76
Hypoxaemia during chest physiotherapy in patients with cystic fibrosis. Ir J Med Sci (1986) 1.74
Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD. Eur Respir J (2008) 1.59
Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome. Eur Respir J (1999) 1.56
Management of obstructive sleep apnea in Europe. Sleep Med (2010) 1.56
Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma. J Clin Invest (1998) 1.46
Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax (2009) 1.45
Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD. Eur Respir J (2007) 1.45
Pulmonary endothelial permeability and circulating neutrophil-endothelial markers in patients undergoing esophagogastrectomy. Crit Care Med (2000) 1.44
Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J (2009) 1.43
A case of progressive multifocal leukoencephalopathy in a patient with sarcoidosis. QJM (2011) 1.38
Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest (2000) 1.35
Inflammation and cancer: macrophage migration inhibitory factor (MIF)--the potential missing link. QJM (2010) 1.29
Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med (2001) 1.29
Cellular mechanisms of acute lung injury: implications for future treatment in the adult respiratory distress syndrome. Thorax (1992) 1.28
The regulation of interleukin-8 by hypoxia in human macrophages--a potential role in the pathogenesis of the acute respiratory distress syndrome (ARDS). Mol Med (2001) 1.21
Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis (1982) 1.18
Public health and medicolegal implications of sleep apnoea. Eur Respir J (2002) 1.14
Is sleep apnoea more common in North America? Lancet (1982) 1.14
Role of respiratory sleep disorders in the pathogenesis of nocturnal angina and arrhythmias. Postgrad Med J (1994) 1.11
Inspiratory flow limitation during sleep in pre-eclampsia: comparison with normal pregnant and nonpregnant women. Eur Respir J (2001) 1.10
Synchronous primary lung cancers: prevalence in surgical material and clinical implications. Thorax (1993) 1.07
Bed partners' assessment of nasal continuous positive airway pressure therapy in obstructive sleep apnea. Chest (1997) 1.01
Effects of positive airway pressure on upper airway dilator muscle activity and ventilatory timing. J Appl Physiol (1985) (1996) 1.00
Acute stridor due to an upper tracheal membrane following endotracheal intubation. Eur Respir J (1999) 1.00
The nose and OSA: variable nasal obstruction may be more important in pathophysiology than fixed obstruction. Eur Respir J (2008) 0.99
Nocturnal deaths among patients with chronic bronchitis and emphysema. Br Med J (Clin Res Ed) (1984) 0.99
Neutrophil chemokines in bronchoalveolar lavage fluid and leukocyte-conditioned medium from nonsmokers and smokers. Eur Respir J (1998) 0.98
Subjective efficacy of nasal CPAP therapy in obstructive sleep apnoea syndrome: a prospective controlled study. Eur Respir J (1999) 0.98
Reflex respiratory response to changes in upper airway pressure in the anaesthetized rat. J Physiol (2001) 0.97
Obstructive sleep apnea following topical oropharyngeal anesthesia in loud snorers. Am Rev Respir Dis (1991) 0.97
Controlled oxygen therapy and carbon dioxide retention during exacerbations of chronic obstructive pulmonary disease. Lancet (2001) 0.97
Potential pro-inflammatory effects of soluble E-selectin upon neutrophil function. Eur J Immunol (1998) 0.96
Theophylline improves gas exchange during rest, exercise, and sleep in severe chronic obstructive pulmonary disease. Am Rev Respir Dis (1993) 0.96
Tuberous sclerosis complex and myocardial fat-containing lesions: a report of four cases. Clin Genet (2007) 0.96
Minimal preparation computed tomography instead of barium enema/colonoscopy for suspected colon cancer in frail elderly patients: an outcome analysis study. Clin Radiol (2004) 0.94
Haemodynamic effects of nasal continuous positive airway pressure in severe congestive heart failure. Eur Respir J (1995) 0.94
Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. Thorax (2004) 0.93
Bronchiolitis obliterans following lung transplantation: early detection using computed tomographic scanning. Thorax (2006) 0.92
Primary cardiac lymphoma: diagnostic tools and treatment challenges. Ir J Med Sci (2009) 0.92
A one-year prospective audit of an asthma education programme in an out-patient setting. Ir Med J (1997) 0.92
Enhanced pulmonary inflammation in organ donors following fatal non-traumatic brain injury. Lancet (1999) 0.91
Adipose tissue in obesity and obstructive sleep apnoea. Eur Respir J (2011) 0.91
Ventilation and gas exchange during sleep in patients with interstitial lung disease. Thorax (1986) 0.91
Modulation of human endothelial thrombomodulin by neutrophils and their release products. Am J Respir Crit Care Med (1997) 0.90
Theophylline in obstructive sleep apnea. A double-blind evaluation. Chest (1992) 0.90
Comparison of three auto-adjusting positive pressure devices in patients with sleep apnoea. Eur Respir J (2006) 0.89
Macrophage migration inhibitory factor: a neuroendocrine modulator of chronic inflammation. J Endocrinol (2003) 0.89
Beneficial effect of oxygen in primary alveolar hypoventilation with central sleep apnea. Am Rev Respir Dis (1982) 0.88
Initial serum ferritin levels in patients with multiple trauma and the subsequent development of acute respiratory distress syndrome. Am J Respir Crit Care Med (1999) 0.86
Ventilation and gas exchange during sleep and exercise in severe COPD. Chest (1996) 0.85
Comparison of a limited computerized diagnostic system (ResCare Autoset) with polysomnography in the diagnosis of obstructive sleep apnoea syndrome. Eur Respir J (1996) 0.85
Abnormal respiratory pattern generation during sleep in patients with autonomic dysfunction. Am Rev Respir Dis (1983) 0.85
Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Postgrad Med J (2009) 0.85
Diagnostic criteria for the sleep apnoea syndrome: time for consensus. Eur Respir J (1996) 0.84
Comparison of oxygen desaturation during sleep and exercise in patients with cystic fibrosis. Chest (1991) 0.84
Imaging spectrum of sudden athlete cardiac death. Clin Radiol (2011) 0.84
Compliance at night with low flow oxygen therapy: a comparison of nasal cannulae and Venturi face masks. Thorax (1995) 0.84
Inflammatory predictors for the development of the adult respiratory distress syndrome. Thorax (1995) 0.83
Upper airway obstruction during sleep in normal subjects after selective topical oropharyngeal anesthesia. Am Rev Respir Dis (1987) 0.83
Clinical and physiologic heterogeneity of the central sleep apnea syndrome. Am Rev Respir Dis (1986) 0.82
Efficacy of nasal continuous positive airway pressure therapy in chronic heart failure: importance of underlying cardiac rhythm. Thorax (1998) 0.82
Sarcoidosis presenting as upper extremity venous thrombosis. Thorax (2003) 0.82
Late-onset central hypoventilation syndrome: a family genetic study. Eur Respir J (2007) 0.82
What is Connected Health and why will it change your practice? QJM (2013) 0.81
Portable monitoring in sleep apnoea: the way forward? Eur Respir J (2011) 0.81
Sleep-related breathing disorders: definitions and measurements. Eur Respir J (2000) 0.81
Towards automated sleep state estimation using a Holter-oximeter. Conf Proc IEEE Eng Med Biol Soc (2007) 0.80
Objective assessment of criteria for selection of donor lungs suitable for transplantation. Thorax (2004) 0.80
Treatment of Robin sequence with nasal CPAP. J Laryngol Otol (1995) 0.80
Impaired detection of added inspiratory resistance in patients with obstructive sleep apnea. Am Rev Respir Dis (1984) 0.80
Reversible hypercapnia in acute exacerbations of chronic obstructive pulmonary disease (COPD). Eur Respir J (1993) 0.80
Effect of respiratory rate on airway deadspace ventilation during exercise in cystic fibrosis. Respir Med (2004) 0.80
Topical oropharyngeal anesthesia in patients with obstructive sleep apnea. Am J Respir Crit Care Med (1995) 0.79
Compliance with nasal CPAP therapy for obstructive sleep apnoea: how much is enough? Eur Respir J (1997) 0.79
Upper lobe bronchiectasis in the yellow nail syndrome: report of a case. Ir J Med Sci (1984) 0.79
Managing exacerbations of COPD: room for improvement. Ir Med J (2004) 0.78
Paradoxical vocal cord motion causing stridor after thyroidectomy. Thorax (2000) 0.78
Comparison of nebulized and sprayed topical anaesthesia for fibreoptic bronchoscopy. Eur Respir J (1992) 0.78
A series of patients on anti-TNF therapy referred to a multidisciplinary lung cancer service. Ir J Med Sci (2012) 0.78
Clinical prediction of the sleep apnea syndrome. Sleep Med Rev (1997) 0.77
Sarcoidosis and MIF gene polymorphism: a case-control study in an Irish population. Eur Respir J (2006) 0.77
Resolution of obstructive sleep apnoea with growth in the Robin sequence. Eur Respir J (1998) 0.77
Oral bisphosphonates improve Bone Mineral Density in adults with cystic fibrosis. Ir Med J (2005) 0.77
Mediators, mechanisms and mortality in major trauma. Resuscitation (1994) 0.76
Oxygen desaturation during sleep and exercise in patients with severe chronic obstructive pulmonary disease. Respir Med (1995) 0.76
Continuous non-invasive monitoring of evolving acute severe asthma during sleep. Thorax (1994) 0.75
Arousal in the sleep apnoea syndrome: a mixed blessing? Eur Respir J (1998) 0.75
Reply to: Increased prevalence of sarcoidosis in Ireland. Ir J Med Sci (2012) 0.75
An unusual cause of orthopnoea. Postgrad Med J (1996) 0.75
Malignant chondroid syringoma presenting as multiple pulmonary nodules. Thorax (1997) 0.75